marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Verrica Pharmaceuticals Financial Ratios 2011-2024 | VRCA
Annual Financial Ratios Verrica Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.7 | -10.3 | -6.5 | -6.9 | -12.9 | -8.5 | - | - | - | - | - | - | - |
P/S |
47.9 | 28.0 | 18.9 | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.5 | -0.7 | -1.3 | -1.7 | -1.1 | -1.4 | -1.6 | - | - | - | - | - | - |
EV (Enterprise Value) |
238 M | 223 M | 258 M | 324 M | 357 M | 168 M | -8.05 M | 3.21 M | - | - | - | - | - |
EBITDA per Share |
-1.44 | -0.61 | -1.13 | -1.6 | -1.2 | -1.49 | - | - | - | - | - | - | - |
EV/EBITDA |
-8.1 | -8.8 | -11.9 | -7.6 | - | - | - | - | - | - | - | ||
PEG |
- | 0.13 | -0.65 | 0.06 | - | - | - | - | - | - | - | ||
P/B |
12.4 | 6.3 | 7.0 | 8.9 | 5.6 | 2.0 | - | - | - | - | - | - | - |
P/CF |
-6.4 | -13.5 | -8.2 | -9.3 | -12.9 | -9.4 | - | - | - | - | - | - | - |
ROE % |
-338.99 | -61.17 | -107.59 | -129.43 | -43.39 | -23.09 | - | - | - | - | - | - | - |
ROA % |
-82.10 | -54.76 | -43.78 | -57.57 | -41.22 | -22.47 | - | - | - | - | - | - | - |
ROCE % |
-332.74 | -53.20 | -94.80 | -115.87 | -46.23 | -24.46 | - | - | - | - | - | - | - |
Current Ratio |
1.3 | 9.5 | 1.7 | 1.7 | 19.4 | 36.8 | - | - | - | - | - | - | - |
DSO |
151.3 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
373.0 | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1084.4 | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
524.3 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-560.1 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Verrica Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.37 | -0.44 | - | -0.54 | -0.24 | -0.15 | - | - | -0.37 | -0.31 | - | -0.47 | -0.43 | -0.04 | - | -0.42 | -0.38 | -0.39 | -0.31 | -0.24 | -0.28 | -0.3 | -0.3 | -0.24 | -0.92 | -0.65 | -0.5 | -0.48 | -0.38 | -0.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.32 | -0.4 | - | - | -0.25 | -0.16 | - | 0.04 | -0.32 | -0.27 | - | -0.42 | -0.39 | - | - | -0.38 | -0.34 | -0.4 | -0.32 | -0.26 | -0.3 | -0.32 | -0.33 | -0.25 | -0.95 | -0.66 | -0.5 | -0.48 | -0.38 | -0.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-1336.25 | -1485.31 | -88.63 | -88.44 | -29.63 | -72.04 | -95.39 | -126.80 | -158.38 | -118.71 | -55.49 | -87.28 | -87.67 | -93.62 | -90.09 | -101.84 | -79.41 | -61.66 | -43.39 | -40.11 | -37.35 | -32.53 | -23.09 | 5.77 | 31.67 | 53.17 | 55.23 | 34.85 | 15.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-114.77 | -99.39 | -52.80 | -52.63 | -26.93 | -25.29 | -27.69 | -42.14 | -56.76 | -52.63 | -27.21 | -41.35 | -41.04 | -41.84 | -40.07 | -51.24 | -46.00 | -43.54 | -41.22 | -38.31 | -35.83 | -31.39 | -22.47 | -30.02 | -38.56 | -44.83 | -42.82 | -27.02 | -12.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-1232.10 | -1367.40 | -88.44 | -85.20 | -25.43 | -60.31 | -81.76 | -110.57 | -142.61 | -107.34 | -49.28 | -78.50 | -78.91 | -84.50 | -85.33 | -97.62 | -78.47 | -63.87 | -46.27 | -43.13 | -40.15 | -34.70 | -24.46 | 5.06 | 31.43 | 53.09 | 55.21 | 34.84 | 15.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 1.0 | 1.3 | 1.8 | 9.2 | 18.1 | 9.5 | 11.2 | 1.4 | 1.6 | 1.7 | 1.9 | 2.1 | 2.3 | 1.8 | 1.8 | 1.8 | 1.8 | 20.1 | 20.1 | 20.1 | 20.1 | 37.1 | 37.1 | 37.1 | 37.1 | 14.8 | 14.8 | 14.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
150.1 | 134.2 | - | 61.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
339.1 | 229.5 | - | 42.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
239.7 | 325.3 | - | 605.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
489.2 | 363.6 | - | 104.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
249.5 | 38.3 | - | -501.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency